(Q38222981)

31 August 2017

0 references

Meta- and cost-effectiveness analysis of commercial weight loss strategies (English)

1 reference

31 August 2017

Eric A Finkelstein

1

1 reference

PubMed ID

24962106

31 August 2017

Eliza Kruger

series ordinal

2

1 reference

31 August 2017

24 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

22

1 reference

31 August 2017

9

1 reference

31 August 2017

1942-1951

1 reference

Systematic review: an evaluation of major commercial weight loss programs in the United States

31 August 2017

1 reference

Long-term drug treatment for obesity: a systematic and clinical review

21 January 2018

1 reference

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

21 January 2018

1 reference

Quantification of the effect of energy imbalance on bodyweight

21 January 2018

1 reference

Weight loss on the web: A pilot study comparing a structured behavioral intervention to a commercial program

21 January 2018

1 reference

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

21 January 2018

1 reference

The estimation of a preference-based measure of health from the SF-12.

21 January 2018

1 reference

Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation

21 January 2018

1 reference

Incremental cost-effectiveness of a collaborative care intervention for panic disorder

21 January 2018

1 reference

Investigating the cost-effectiveness of videotelephone based support for newly diagnosed paediatric oncology patients and their families: design of a randomised controlled trial

21 January 2018

1 reference

Weight loss with self-help compared with a structured commercial program: a randomized trial.

21 January 2018

1 reference

Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial

21 January 2018

1 reference

Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: a randomized controlled trial

21 January 2018

1 reference

Randomized trial of a multifaceted commercial weight loss program.

21 January 2018

1 reference

Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study

21 January 2018

1 reference

Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension

21 January 2018

1 reference

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes.

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet

21 January 2018

1 reference

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial

21 January 2018

1 reference

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

21 January 2018

1 reference

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial

21 January 2018

1 reference

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin

21 January 2018

1 reference

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

21 January 2018

1 reference

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

Effect of orlistat on cardiovascular disease risk in obese adults

21 January 2018

1 reference

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

21 January 2018

1 reference

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

21 January 2018

1 reference

A randomized controlled trial of a commercial internet weight loss program

21 January 2018

1 reference

Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: a controlled clinical trial.

21 January 2018

1 reference

Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial

21 January 2018

1 reference

Weight control in the physician's office

21 January 2018

1 reference

Meal replacements in weight intervention

21 January 2018

1 reference

Value of structured meals for weight management: risk factors and long-term weight maintenance

21 January 2018

1 reference

A comparison of meal replacements and medication in weight maintenance after weight loss

21 January 2018

1 reference

Nutrient adequacy during weight loss interventions: a randomized study in women comparing the dietary intake in a meal replacement group with a traditional food group

21 January 2018

1 reference

Results of soy-based meal replacement formula on weight, anthropometry, serum lipids & blood pressure during a 40-week clinical weight loss trial

21 January 2018

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)

21 January 2018

1 reference

An economic analysis of traditional and technology-based approaches to weight loss

21 January 2018

1 reference

Cost-effectiveness of interventions to promote physical activity: a modelling study

21 January 2018

1 reference

Orlistat for the treatment of obesity: cost utility model

21 January 2018

1 reference

Orlistat for the treatment of obesity: rapid review and cost-effectiveness model

21 January 2018

1 reference

The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach

21 January 2018

1 reference

Economic evaluation of treatment with orlistat in Italian obese patients

21 January 2018

1 reference

Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland

21 January 2018

1 reference

A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents

21 January 2018

1 reference

Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus

21 January 2018

1 reference

Economic evaluation of weight loss interventions in overweight and obese women.

21 January 2018

1 reference

Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases

21 January 2018

1 reference

Foreign free riders and the high price of US medicines

21 January 2018

1 reference

Cost-effectiveness of Weight Watchers and the Lighten Up to a Healthy Lifestyle program

21 January 2018

1 reference

Cost-effectiveness of sibutramine in the treatment of obesity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.20824

1 reference

31 August 2017

1 reference

PubMed ID

24962106